Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Depreciation & Amortization (CF) (2020 - 2022)

Historic Depreciation & Amortization (CF) for Pharming (PHAR) over the last 3 years, with Q4 2022 value amounting to $2.2 million.

  • Pharming's Depreciation & Amortization (CF) rose 615.61% to $2.2 million in Q4 2022 from the same period last year, while for Sep 2023 it was $2.2 million, marking a year-over-year increase of 583.72%. This contributed to the annual value of $8.3 million for FY2020, which is 4332.01% up from last year.
  • Per Pharming's latest filing, its Depreciation & Amortization (CF) stood at $2.2 million for Q4 2022, which was up 615.61% from -$4.3 million recorded in Q3 2022.
  • In the past 5 years, Pharming's Depreciation & Amortization (CF) ranged from a high of $2.3 million in Q3 2020 and a low of -$4.4 million during Q3 2021
  • Its 3-year average for Depreciation & Amortization (CF) is $269916.2, with a median of $2.1 million in 2021.
  • The largest annual percentage gain for Pharming's Depreciation & Amortization (CF) in the last 5 years was 2368070.4% (2021), contrasted with its biggest fall of 29163.23% (2021).
  • Pharming's Depreciation & Amortization (CF) (Quarter) stood at $8675.1 in 2020, then surged by 23680.7% to $2.1 million in 2021, then rose by 6.16% to $2.2 million in 2022.
  • Its last three reported values are $2.2 million in Q4 2022, -$4.3 million for Q3 2022, and $2.1 million during Q2 2022.